dc.contributor.author |
Flores de los Heros, África, 1985- |
dc.contributor.author |
Valls Comamala, Victòria, 1987- |
dc.contributor.author |
Costa, Giulia |
dc.contributor.author |
Saravia Santos, Rocio, 1988- |
dc.contributor.author |
Maldonado, Rafael, 1961- |
dc.contributor.author |
Berrendero Díaz, Fernando, 1971- |
dc.date.accessioned |
2016-01-22T07:54:51Z |
dc.date.available |
2016-01-22T07:54:51Z |
dc.date.issued |
2014 |
dc.identifier.citation |
Flores Á, Valls-Comamala V, Costa G, Saravia R, Maldonado R, Berrendero F. The hypocretin/orexin system mediates the extinction of fear memories. Neuropsychopharmacology. 2014 Nov;39(12):2732-41. DOI: 10.1038/npp.2014.146 |
dc.identifier.issn |
0893-133X |
dc.identifier.uri |
http://hdl.handle.net/10230/25633 |
dc.description.abstract |
Anxiety disorders are often associated with an inability to extinguish learned fear responses. The hypocretin/orexin system is involved in the regulation of emotional states and could also participate in the consolidation and extinction of aversive memories. Using hypocretin receptor-1 and hypocretin receptor-2 antagonists, hypocretin-1 and hypocretin-2 peptides, and hypocretin receptor-1 knockout mice, we investigated the role of the hypocretin system in cue- and context-dependent fear conditioning and extinction. Hypocretins were crucial for the consolidation of fear conditioning, and this effect was mainly observed in memories with a high emotional component. Notably, after the acquisition of fear memory, hypocretin receptor-1 blockade facilitated fear extinction, whereas hypocretin-1 administration impaired this extinction process. The extinction-facilitating effects of the hypocretin receptor-1 antagonist SB334867 were associated with increased expression of cFos in the basolateral amygdala and the infralimbic cortex. Intra-amygdala, but neither intra-infralimbic prefrontal cortex nor intra-dorsohippocampal infusion of SB334867 enhanced fear extinction. These results reveal a key role for hypocretins in the extinction of aversive memories and suggest that hypocretin receptor-1 blockade could represent a novel therapeutic target for the treatment of diseases associated with inappropriate retention of fear, such as post-traumatic stress disorder and phobias. |
dc.description.sponsorship |
This work was supported by the Instituto de Salud Carlos III grants, #PI13/00042 and #RD12/0028/0023 (RTA-RETICS), by the Spanish Ministry of Science #SAF2011-29864, the/nCatalan Government (SGR2009-00731), and by the Catalan Institution for Research and Advanced Studies (ICREA Academia program). África Flores is a recipient of a predoctoral fellowship from the Spanish Ministry of Education. |
dc.format.mimetype |
application/pdf |
dc.language.iso |
eng |
dc.publisher |
Nature Publishing Group |
dc.relation.ispartof |
Neuropsychopharmacology. 2014 Nov;39(12):2732-41 |
dc.rights |
© Nature Publishing Group. http://dx.doi.org/10.1038/npp.2014.146 |
dc.subject.other |
Extinció psicològica |
dc.subject.other |
Por -- Aspectes fisiològics |
dc.subject.other |
Pèptids |
dc.subject.other |
Memòria -- Aspectes fisiològics |
dc.title |
The hypocretin/orexin system mediates the extinction of fear memories |
dc.type |
info:eu-repo/semantics/article |
dc.identifier.doi |
http://dx.doi.org/10.1038/npp.2014.146 |
dc.relation.projectID |
info:eu-repo/grantAgreement/ES/3PN/SAF2011-29864 |
dc.rights.accessRights |
info:eu-repo/semantics/openAccess |
dc.type.version |
info:eu-repo/semantics/acceptedVersion |